Granting of a Health Research Fund FIS project to the Translational Hematopathology group

Recently, an aid for the health research project PI19 / 00041 has been granted to Santiago Montes Moreno, Principal Investigator, head of the emerging IDIVAL group of Translational Hematopathology.

The project, entitled “Liquid Biopsy for the molecular diagnosis of patients with aggressive B lymphoma included in a clinical trial”, is a multicenter effort whose objective is to consolidate a histopathological and molecular diagnostic platform for patients with large cell B lymphoma included in different clinical trials of the GELTAMO group.

The project includes as specific objectives:

1. The genetic characterization of patient samples using the latest generation technology available (Last Generation Sequencing from liquid biopsy).
2. The evaluation of the impact of genetic complexity on the antitumor response of T cells.

The concession of this project supposes the continued support by the Carlos III Health Institute to the Translational Hematopathology group, which has as one of its main lines of research the identification of genetic markers in aggressive Lymphoma B that may be useful for prognosis and selection of targeted therapy.